Trial · NCT02106975
Outcomes21
Each outcome the trial posted results for, in ClinicalTrials.gov's words.
1 to 20 of 21
Download this page as JSON| Type | Outcome | Time frame | Population | Units | Measured as |
|---|---|---|---|---|---|
| PRIMARY | Modified Change in Sequential Organ Failure Assessment (mSOFA) Score | 96 hours | 3 participants were omitted from the analysis because the etiology of the patients SEPSIS was not representative of the typical SEPSIS patient | score on a scale | MEAN |
| PRIMARY | C-Reactive Protein at Study Hours 0, 48, 96, 168 When Compared to Placebo | up to 168 hours | 3 participants were omitted from the analysis because the etiology of the patients SEPSIS was not representative of the typical SEPSIS patient | µg/ml | MEAN |
| PRIMARY | Thrombomodulin Protein at Study Hours 0, 48, 96, 168 When Compared to Placebo | Up to 168 hours | ng/ml | MEAN | |
| SECONDARY | Oxygenation Index (FiO2 x Mean Airway Pressure/PaO2) at Study Hour 0, 48, 96, 168 if Still Intubated in Ascorbate Infused Patient Compared to Placebo. | Up to hour 168 | 3 participants were omitted from the analysis because the etiology of the patients SEPSIS was not representative of the typical SEPSIS patient | Index | MEAN |
| SECONDARY | VE-40 (Vent RR x TV/Weight) x (PaCO2/40) at Study Hour 0, 48, 96, 168 if Still Intubated, in Ascorbate Infused Patient Compared to Placebo | Up to hour 168 | 3 participants were omitted from the analysis because the etiology of the patients SEPSIS was not representative of the typical SEPSIS patient | mmMercury | MEAN |
| SECONDARY | mSOFA Scores at Hours 0, 48, 96 | Up to hour 96 | 3 participants were omitted from the analysis because the etiology of the patients SEPSIS was not representative of the typical SEPSIS patient | units on a scale | MEDIAN |
| SECONDARY | Ascorbate Level at Hour 0, 48, 96, 168 | Up to hour 168 | 3 participants were omitted from the analysis because the etiology of the patients SEPSIS was not representative of the typical SEPSIS patient | µM | MEAN |
| SECONDARY | Ventilator Free Days to Day 28 | Up to Day 28 | 3 participants were omitted from the analysis because the etiology of the patients SEPSIS was not representative of the typical SEPSIS patient | days | MEAN |
| SECONDARY | ICU-free Days at Day 28 | Up to Day 28 | 3 participants were omitted from the analysis because the etiology of the patients SEPSIS was not representative of the typical SEPSIS patient | days | MEAN |
| SECONDARY | All Cause Mortality to Day 28 | Up to Day 28 | 3 participants were omitted from the analysis because the etiology of the patients SEPSIS was not representative of the typical SEPSIS patient | percentage of participants | NUMBER |
| SECONDARY | Hospital-free Days at Day 60 | Up to Day 60 | 3 participants were omitted from the analysis because the etiology of the patients SEPSIS was not representative of the typical SEPSIS patient | days | MEAN |
| SECONDARY | Procalcitonin at Study Hour 0, 48, 96, 168 | Up to hour 168 | 3 participants were omitted from the analysis because the etiology of the patients SEPSIS was not representative of the typical SEPSIS patient | ng/ml | MEAN |
| SECONDARY | Receptor for Advanced Glycation Endpoints at Study Hour 0, 48, 96, 168 | Up to hour 168 | 3 participants were omitted from the analysis because the etiology of the patients SEPSIS was not representative of the typical SEPSIS patient | ng/ml | MEAN |
| SECONDARY | Tissue Factor Pathway Inhibitor at Study Hour 0, 48, 96, 168 | Up to hour 168 | 3 participants were omitted from the analysis because the etiology of the patients SEPSIS was not representative of the typical SEPSIS patient | ng/ml | MEAN |
| SECONDARY | Oxygenation Score: Pressure | Up to hour 168 | 3 participants were omitted from the analysis because the etiology of the patients SEPSIS was not representative of the typical SEPSIS patient | mm Mercury | MEAN |
| SECONDARY | Oxygenation Score: Saturation | Up to hour 168 | 3 participants were omitted from the analysis because the etiology of the patients SEPSIS was not representative of the typical SEPSIS patient | Ratio | MEAN |
| SECONDARY | Coagulation | Up to hour 168 | 3 participants were omitted from the analysis because the etiology of the patients SEPSIS was not representative of the typical SEPSIS patient | Platelets/uL of Blood | MEAN |
| SECONDARY | Liver Function | Up to hour 168 | 3 participants were omitted from the analysis because the etiology of the patients SEPSIS was not representative of the typical SEPSIS patient | Mg/dL | MEDIAN |
| SECONDARY | Cardiovascular Function | Up to hour 168 | 3 participants were omitted from the analysis because the etiology of the patients SEPSIS was not representative of the typical SEPSIS patient | mmHg | MEAN |
| SECONDARY | State of Consciousness | Up to hour 168 | 3 participants were omitted from the analysis because the etiology of the patients SEPSIS was not representative of the typical SEPSIS patient | units on a scale | MEDIAN |
Source ClinicalTrials.govtrials-2026-11-12-0.5.0
Sources 3
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ClinicalTrials.govNo license stated
- NIH RePORTER's clinical studies and project filesPublic domain
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ClinicalTrials.govnone stated
- NIH RePORTER's clinical studies and project filesPublic domain (NIH RePORTER)
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/trials/v1/NCT02106975/outcomes